Cartalax 20MG is a 20-milligram format of Cartalax, a short peptide fragment developed in Russian peptide bioregulator research. Researchers study Cartalax in preclinical and exploratory settings related to cartilage biology, extracellular matrix signaling, and connective tissue models. Interest often focuses on how small regulatory peptides may influence gene expression patterns in cell and tissue systems.